Advisory Board

Jolene Varney has held the positions of CFO, Treasurer, General Manager and M&A/Strategic Planning and has led large systems and restructuring programs. Her industry experience includes Consumer Products, B2B / Industrial, Healthcare and Pharmaceutical.  

Jolene spent 18 years with Kimberly-Clark Corporation in Finance, General Management, and led large company-wide projects. Her last position was Global Treasurer and prior to that, she lived and worked across the European business running the Central & Eastern European business and retail healthcare business. She was the CFO in a $2Bn division and worked in the headquarters’ Strategic Planning / M&A division. 

In addition to her years at Kimberly-Clark, she took Dr Pepper Snapple Group public in 2008, was the CFO for Pharmaceutical company taking a new drug through FDA to market and Division CFO for the $12Bn Fresenius Dialysis business. She has been a CFO to PE-backed high growth and turnaround businesses, taking one through a successful sale and exit.   

Jolene now is principal in her consulting company and works with Fresenius Medical Care, working with Fresenius Medical Care in their international business and real estate team. She is on several Advisory Boards including Synergen Heath and an early-stage Women’s Health company. She is also an active real estate investor and developer.  

Travis Meyer is a Partner in the Chicago office. He is a core member of BCG’s Transaction & Integration Excellence and People and Organization's Practice Areas with specific focus managing complex PMIs and organization design in the healthcare industry.

Prior to joining BCG, Travis worked for ZSAssociates, a consulting firm with a focus on sales and marketing. At ZS he had extensive experience in sales force strategy, post merger sales force integration, market research, and sales force deployment. He worked in a diverse set of industries with a primary focus on medical device companies. 

Selection of his project experience includes:

•Central IMO for a global 10B+ MedTech integration that overdelivered cost synergies by 200+% •Go-to-market strategy and execution plan for a MedTech integration •Transformation office for a growth led transformation at a global MedTech company •Post-merger organization integration of two healthcare companies with a combined global organization +50,000 •Global Operating model and organization redesign for an 80,000+ OEM 

Matt Liebers is a physician, health tech entrepreneur and investor. Matt is from upstate New York where he attended Cornell University. He spent time working in cancer research and in management consulting at Mckinsey. He received his medical degree from The Icahn School of Medicine at Mount Sinai. In addition to his work in the life sciences, Matt actively invests in multi-family and industrial real estate projects. In his spare time, Matt enjoys traveling, hiking and birding. 

 Vice President of Business Development & Strategy at DH Diagnostics LLC, a leading company in the diagnostics industry that provides innovative and impactful solutions for patients and customers. With an MD and a management consulting background, over 15 years of experience in leading and supporting strategic growth and performance initiatives across different segments and markets in the healthcare sector.

Core competencies include strategy formulation and execution, M&A, stakeholder management, and cross-functional collaboration. Successfully led and supported multiple high-priority initiatives, such as deal sourcing, cultivation and execution, asset growth, and commercial optimization, in his current and previous roles at DH Diagnostics, Pall Corporation, and Mallinckrodt Pharmaceuticals. Passionate about delivering value and quality to the customers and patients they serve, and fostering a diverse and inclusive culture that values teamwork, excellence, and continuous learning.